Company intelligence / Profile preview

Camtech Diagnostics

Cambridge, England, United Kingdom

Ownership: Private
Employees: ~26
Development stage: Other

Overview

Camtech Diagnostics has commercialised a range of rapid point-of-care and laboratory-based diagnostic and genetic testing platforms, with validated products for infectious diseases, genetic risk, and food safety, and active collaborations for AI-driven antimicrobial resistance prediction. Clinical results are in-market, supporting accurate, scalable, and non-invasive diagnoses for consumer and clinical applications.

Therapeutic areas: OncologyInfectious DiseasesOther
Modalities: DeviceMicrofluidicsMolecular diagnosticsGenetic testingPoint-of-care diagnostics
Industry: Molecular Diagnostics

Partnerships

Congenica (genomic analysis in Asia)European Vaccine Initiative (DRAIGON project)GE Healthcare (global innovation partnership)

Beyond the preview

Go deeper on Camtech Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Camtech Diagnostics.

Explore the full profile